LABTECHS
Japan · Biotech · Healthtech
LABTECHS develops rapid sterility testing kits and reagents from research at the University of Toyama.
Product
LABTECHS develops tools that help pharmaceutical manufacturers and medical laboratories test for microbial contamination more quickly. The University of Toyama spinout sells Decontami-Tech, a rapid sterility testing kit based on nucleic acid amplification.
The company is also developing a reagent intended to shorten testing times alongside existing methods. Its work targets applications including platelet products and regenerative medicines, where short product lifetimes make slow testing difficult.
Funding history
2 rounds · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| T-CAF investment commitment | Undisclosed | Toyama Co-Accel Fund (T-CAF) — Participant | |
| Go-Tech research grant selection | Undisclosed | Ministry of Economy, Trade and Industry (METI) — Participant |
Investors
Toyama Co-Accel Fund (T-CAF)Joined T-CAF investment commitmentMinistry of Economy, Trade and Industry (METI)Joined Go-Tech research grant selectionCoverage
Nov 11, 2026LABTECHS · T-CAF investment commitmentJul 8, 2025LABTECHS · Go-Tech research grant selectionSimilar companies
BMBoston Medical SciencesBoston Medical Sciences develops AI-assisted colorectal cancer screening technology.¥5.6B · Series B
SSSunlit SeedlingsSunlit Seedlings measures biodiversity and microbial activity to help organisations assess and redesign ecosystems.Undisclosed · Corporate investment
BiomatterBiomatter designs custom enzymes for pharmaceutical, diagnostic, agricultural and industrial applications.$18M · Series A